GEN Exclusives

More »

GEN News Highlights

More »
Jan 21, 2010

Roche Expands Agreement with b3 bio to Include Therapeutic Technologies

  • b3 bio signed an agreement with Roche to source and develop innovative early-stage technologies that could result in potential therapeutic benefits. Roche will have certain rights for further development and/or commercialization of such technologies. As part of this agreement, Roche will increase its equity investment in b3 bio as well as provide development funds.

    b3 bio and Roche started their partnership in July, 2008. The initial arrangement focused on the development of delivery systems for a range of drug candidates and diagnostic cargos.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »